| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 40276 | Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Resear... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 4, 2028 Open | Grants.gov |
|
Source description
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to develop and/or enhance predoctoral and postdoctoral research training, including short-term research training, to help ensure that a highly trained workforce is available to meet the needs of the Nations biomedical, behavioral, and clinical research agenda. Research training programs are expected to incorporate engaging, didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. Programs proposing only short-term predoctoral research training should not apply to this announcement, but rather to the Kirschstein-NRSA Short-Term Institutional Research Training Grant Program (T35) exclusively reserved for predoctoral, short-term research training.This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor. |
||||||
| 40277 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40278 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-07 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40279 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-07 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40280 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40281 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-07 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40282 | Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: IKK classic | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40283 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40284 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40285 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Propranolol (ausschließlich Darreichungsform LSE), ATC C07AA05 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40286 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin alfa und zeta), ATC B03XA01 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40287 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Piribedil, ATC N04BC08 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40288 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ixekizumab, ATC L04AC13 für die Zeit 01.07.2026 - 30.06.2028 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40289 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fusidinsäure, ATC D06AX01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40290 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lapatinib, ATC L01EH01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x 12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40291 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cyanocobalamin, ATC B03BA01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x 12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40292 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Epinephrin, ATC C01CA24 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40293 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lenalidomid, ATC L04AX04 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40294 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Carglumsäure, ATC A16AA05 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-05-05 |
||||||
| 40295 | France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-France Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Dea... | Tender Procurement Contract | France | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05 |
||||||
| 40296 | France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-France Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Dea... | Tender Procurement Contract | France | Not provided on the source page. Please check the official source. | Open May 5, 2028 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05 |
||||||
| 40297 | Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical te... | Grant Cash Grant | United States | Award ceiling: $1,000,000 | Open May 7, 2028 Open | Grants.gov |
|
Source description
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD. |
||||||
| 40298 | Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Instituti... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2028 Open | Grants.gov |
|
Source description
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers within biomedical, behavioral, or clinical research workforce. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue interests in research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research. |
||||||
| 40299 | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is t... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2028 Open | Grants.gov |
|
Source description
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. |
||||||
| 40300 | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open May 7, 2028 Open | Grants.gov |
|
Source description
The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. |
||||||